Cilostazol from Japan
Cilostazol is a quinolinone phosphodiesterase III inhibitor used for intermittent claudication in peripheral artery disease. Its nitrogen-heterocyclic structure qualifies under HTS 2933.99.53.00 as cardiovascular drug. Bulk powder for 50/100mg tablet production.
Duty Rate — Japan → United States
6.5%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Poor solubility - laser diffraction PSD critical for BE
• Quinolinone photo-degradation risk - amber packaging mandatory
• CYP3A4 inhibitor - include drug interaction dossier